EPISODE · Nov 30, 2025 · 43 MIN

Dillan DiNardo: AI In Psychedelic Drug Development

from Mycopreneur

Dillan DiNardo, Co-Founder and CEO of Mindstate Design Labs, returns to the Mycopreneur Podcast to share updates on the companies progress as a clinical-stage AI neuroengineering platform and drug development outfit. We explore how Mindstate Design is leveraging artificial intelligence in their drug development process, discuss the origins of the company and it's connection to legendary drug chemist Alexander "Sasha" Shulgin, and cover the evolving landscape of psychedelic drug research and where it could all go from here.Please rate and review wherever you're listening ( : Hosted on Acast. See acast.com/privacy for more information.